6186-full
Thekla
Sex: F
Data Quality: 2 stars
MS: 15 yrs
Type: Secondary Progressive
Sensation: Moderate
Overall: Mild
Cognition: none
Vision: none
Speech: none
Swallowing: none
Upper limb: moderate
Walking: severe
Thekla
Female, 49 years
Germany
Primary Condition
MS
Type
Secondary Progressive
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

Thekla's Low Dose Naltrexone (LDN) is for:

  • MS

Thekla's side effects of Low Dose Naltrexone (LDN):

Thekla's Low Dose Naltrexone (LDN) History (Stopped)
Low Dose Naltrexone (LDN) (naltrexone)
3.75 mg Daily Feb 15, 2004 - Dec 14, 2008
4 mg Daily Dec 14, 2008 - Sep 01, 2011
4 mg M,W,F Sep 01 - 30, 2011
2.5 mg Daily Mar 30 - Aug 01, 2012
Stopped Other Sep 30, 2011
Stopped Doctor's advice Aug 01, 2012
Evaluations
Date Dosage MS (Multiple Sclerosis) Perceived effectiveness Side Effects Adherence Burden
Aug 01, 2012 2.5 mg Daily Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_default ModerateModerateModerateModerate AlwaysAlwaysAlwaysAlways A littleA littleA littleA little
Sep 30, 2011 4 mg M,W,F Led_efficacy_2Led_efficacy_2Led_defaultLed_default ModerateModerateModerateModerate AlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at all
Date
Sep 30, 2011
Advice & Tips
It really seemed to help for years but we suspect that I have become sensitized to it. It was suggested that I drop my dosage to 2mg but it is very difficult to obtain here.

About Low Dose Naltrexone (LDN) (Prescription Drug)

Naltrexone is FDA approved for alcohol and opioid dependence at 50mg doses. Pilot and preliminary studies of its use in low doses suggest there may be some positive effect for certain conditions. Read more...Click to read more below

Learn more about Low Dose Naltrexone (LDN) in our Low Dose Naltrexone (LDN) Community Report.